Clinical trial
Clinical Trial of Memantine for Major Depression
NCT00040261 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00040261 |
|---|---|
| Title | Clinical Trial of Memantine for Major Depression |
| Official title | An Investigation of the Antidepressant Efficacy of Memantine, an NMDA Antagonist With Neurotrophic Properties in Major Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Memantine HCL |
| Enrollment | 112 |
| Start date | Jun 1, 2002 |
| Completion | Mar 1, 2005 |
| First posted | Jun 24, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: